TABLE 1.

Demographic Characteristics of the 62,843 Inpatients Receiving Antifungal Therapy, 2000–2006

Characteristic	Frequency Within Entire Cohort (%)
Year of discharge
2000	7690 (12%)
2001	7691 (12%)
2002	8118 (13%)
2003	8599 (14%)
2004	9588 (15%)
2005	10,469 (17%)
2006	10,688 (17%)
Fungal diagnosis by year of discharge
2000	1767 (3%)
2001	1826 (3%)
2002	1965 (3%)
2003	2242 (4%)
2004	2275 (4%)
2005	1839 (3%)
2006	2397 (4%)
Death during hospitalization	5144 (8%)
At least one underlying condition*	49,411 (79%)
Malignancy†	26,548 (42%)
Hematologic/immunologic deficiency†	9817 (16%)
Cardiovascular condition†	9491 (15%)
Neonate‡	5839 (9%)
Neuromuscular condition†	5215 (8%)
Respiratory condition†	4684 (7%)
Other congenital condition†	4498 (7%)
Bone marrow transplant‡	3398 (5%)
Metabolic condition†	3364 (5%)
Gastrointestinal condition†	2593 (4%)
Renal condition†	1695 (3%)
Solid organ transplant‡	1206 (2%)

^*Percentages do not add to 100 as individuals could have more than one underlying condition.

^†Determined by CCC.

^‡Determined by APR-DRG v20.